1. Home
  2. PTCT vs NOVT Comparison

PTCT vs NOVT Comparison

Compare PTCT & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

SELL

Current Price

$63.51

Market Cap

5.5B

Sector

Health Care

ML Signal

SELL

Logo Novanta Inc.

NOVT

Novanta Inc.

SELL

Current Price

$143.46

Market Cap

5.0B

Sector

Miscellaneous

ML Signal

SELL

Company Overview

Basic Information
Metric
PTCT
NOVT
Founded
1998
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
5.5B
5.0B
IPO Year
2006
1999

Fundamental Metrics

Financial Performance
Metric
PTCT
NOVT
Price
$63.51
$143.46
Analyst Decision
Buy
Strong Buy
Analyst Count
14
3
Target Price
$101.07
★ $194.50
AVG Volume (30 Days)
★ 1.2M
360.5K
Earning Date
11-03-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 264.48
N/A
EPS
★ 0.90
0.82
Revenue
$264,734,000.00
★ $521,290,000.00
Revenue This Year
N/A
$15.57
Revenue Next Year
$9.26
$15.87
P/E Ratio
★ $71.38
$173.98
Revenue Growth
★ 36.19
35.49
52 Week Low
$61.23
$98.27
52 Week High
$90.87
$176.38

Technical Indicators

Market Signals
Indicator
PTCT
NOVT
Relative Strength Index (RSI) 40.49 49.53
Support Level $62.46 $141.72
Resistance Level $72.86 $150.66
Average True Range (ATR) 2.00 5.19
MACD 0.19 0.24
Stochastic Oscillator 38.57 48.75

Price Performance

Historical Comparison
PTCT
NOVT

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

About NOVT Novanta Inc.

Novanta Inc supplies core technology solutions to medical, life science, and advanced industrial OEMs, leveraging proprietary expertise in precision medicine, precision manufacturing, robotics and automation, and advanced surgery. It has two segments: Automation Enabling Technologies and Medical Solutions. Automation Enabling Technologies, which generates the majority of revenue, provides laser beam steering and scanning solutions, laser sources, and robotic and precision motion technologies. The Medical Solutions segment provides medical-grade technologies, including medical insufflators, endoscopic pumps, and integrated operating room technologies. The company operates in the United States, Germany, and other markets, with revenue generated from the United States.

Share on Social Networks: